Table of Content

1 Study Coverage
1.1 Long-acting and Short-acting Oral Contraceptives Product Introduction
1.2 Market by Type
1.2.1 Global Long-acting and Short-acting Oral Contraceptives Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Combined Contraceptive Pill
1.2.3 Low Dose Oral Contraceptive
1.3 Market by Application
1.3.1 Global Long-acting and Short-acting Oral Contraceptives Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Long-acting and Short-acting Oral Contraceptives Sales Estimates and Forecasts 2018-2029
2.2 Global Long-acting and Short-acting Oral Contraceptives Revenue by Region
2.2.1 Global Long-acting and Short-acting Oral Contraceptives Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Long-acting and Short-acting Oral Contraceptives Revenue by Region (2018-2024)
2.2.3 Global Long-acting and Short-acting Oral Contraceptives Revenue by Region (2024-2029)
2.2.4 Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Region (2018-2029)
2.3 Global Long-acting and Short-acting Oral Contraceptives Sales Estimates and Forecasts 2018-2029
2.4 Global Long-acting and Short-acting Oral Contraceptives Sales by Region
2.4.1 Global Long-acting and Short-acting Oral Contraceptives Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Long-acting and Short-acting Oral Contraceptives Sales by Region (2018-2024)
2.4.3 Global Long-acting and Short-acting Oral Contraceptives Sales by Region (2024-2029)
2.4.4 Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Long-acting and Short-acting Oral Contraceptives Sales by Manufacturers
3.1.1 Global Long-acting and Short-acting Oral Contraceptives Sales by Manufacturers (2018-2024)
3.1.2 Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Long-acting and Short-acting Oral Contraceptives in 2022
3.2 Global Long-acting and Short-acting Oral Contraceptives Revenue by Manufacturers
3.2.1 Global Long-acting and Short-acting Oral Contraceptives Revenue by Manufacturers (2018-2024)
3.2.2 Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Long-acting and Short-acting Oral Contraceptives Revenue in 2022
3.3 Global Key Players of Long-acting and Short-acting Oral Contraceptives, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Long-acting and Short-acting Oral Contraceptives Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Long-acting and Short-acting Oral Contraceptives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Long-acting and Short-acting Oral Contraceptives, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Long-acting and Short-acting Oral Contraceptives, Product Offered and Application
3.8 Global Key Manufacturers of Long-acting and Short-acting Oral Contraceptives, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Long-acting and Short-acting Oral Contraceptives Sales by Type
4.1.1 Global Long-acting and Short-acting Oral Contraceptives Historical Sales by Type (2018-2024)
4.1.2 Global Long-acting and Short-acting Oral Contraceptives Forecasted Sales by Type (2024-2029)
4.1.3 Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Type (2018-2029)
4.2 Global Long-acting and Short-acting Oral Contraceptives Revenue by Type
4.2.1 Global Long-acting and Short-acting Oral Contraceptives Historical Revenue by Type (2018-2024)
4.2.2 Global Long-acting and Short-acting Oral Contraceptives Forecasted Revenue by Type (2024-2029)
4.2.3 Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Type (2018-2029)
4.3 Global Long-acting and Short-acting Oral Contraceptives Price by Type
4.3.1 Global Long-acting and Short-acting Oral Contraceptives Price by Type (2018-2024)
4.3.2 Global Long-acting and Short-acting Oral Contraceptives Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Long-acting and Short-acting Oral Contraceptives Sales by Application
5.1.1 Global Long-acting and Short-acting Oral Contraceptives Historical Sales by Application (2018-2024)
5.1.2 Global Long-acting and Short-acting Oral Contraceptives Forecasted Sales by Application (2024-2029)
5.1.3 Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Application (2018-2029)
5.2 Global Long-acting and Short-acting Oral Contraceptives Revenue by Application
5.2.1 Global Long-acting and Short-acting Oral Contraceptives Historical Revenue by Application (2018-2024)
5.2.2 Global Long-acting and Short-acting Oral Contraceptives Forecasted Revenue by Application (2024-2029)
5.2.3 Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Application (2018-2029)
5.3 Global Long-acting and Short-acting Oral Contraceptives Price by Application
5.3.1 Global Long-acting and Short-acting Oral Contraceptives Price by Application (2018-2024)
5.3.2 Global Long-acting and Short-acting Oral Contraceptives Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Long-acting and Short-acting Oral Contraceptives Market Size by Type
6.1.1 US & Canada Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2029)
6.1.2 US & Canada Long-acting and Short-acting Oral Contraceptives Revenue by Type (2018-2029)
6.2 US & Canada Long-acting and Short-acting Oral Contraceptives Market Size by Application
6.2.1 US & Canada Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2029)
6.2.2 US & Canada Long-acting and Short-acting Oral Contraceptives Revenue by Application (2018-2029)
6.3 US & Canada Long-acting and Short-acting Oral Contraceptives Market Size by Country
6.3.1 US & Canada Long-acting and Short-acting Oral Contraceptives Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2029)
6.3.3 US & Canada Long-acting and Short-acting Oral Contraceptives Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Long-acting and Short-acting Oral Contraceptives Market Size by Type
7.1.1 Europe Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2029)
7.1.2 Europe Long-acting and Short-acting Oral Contraceptives Revenue by Type (2018-2029)
7.2 Europe Long-acting and Short-acting Oral Contraceptives Market Size by Application
7.2.1 Europe Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2029)
7.2.2 Europe Long-acting and Short-acting Oral Contraceptives Revenue by Application (2018-2029)
7.3 Europe Long-acting and Short-acting Oral Contraceptives Market Size by Country
7.3.1 Europe Long-acting and Short-acting Oral Contraceptives Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2029)
7.3.3 Europe Long-acting and Short-acting Oral Contraceptives Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Long-acting and Short-acting Oral Contraceptives Market Size
8.1.1 China Long-acting and Short-acting Oral Contraceptives Sales (2018-2029)
8.1.2 China Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029)
8.2 China Long-acting and Short-acting Oral Contraceptives Market Size by Application
8.2.1 China Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2029)
8.2.2 China Long-acting and Short-acting Oral Contraceptives Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Long-acting and Short-acting Oral Contraceptives Market Size by Type
9.1.1 Asia Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2029)
9.1.2 Asia Long-acting and Short-acting Oral Contraceptives Revenue by Type (2018-2029)
9.2 Asia Long-acting and Short-acting Oral Contraceptives Market Size by Application
9.2.1 Asia Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2029)
9.2.2 Asia Long-acting and Short-acting Oral Contraceptives Revenue by Application (2018-2029)
9.3 Asia Long-acting and Short-acting Oral Contraceptives Sales by Region
9.3.1 Asia Long-acting and Short-acting Oral Contraceptives Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Long-acting and Short-acting Oral Contraceptives Revenue by Region (2018-2029)
9.3.3 Asia Long-acting and Short-acting Oral Contraceptives Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Market Size by Type
10.1.1 Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Market Size by Application
10.2.1 Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Sales by Country
10.3.1 Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Overview
11.1.3 Bayer Long-acting and Short-acting Oral Contraceptives Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Bayer Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Paladin Labs
11.2.1 Paladin Labs Company Information
11.2.2 Paladin Labs Overview
11.2.3 Paladin Labs Long-acting and Short-acting Oral Contraceptives Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Paladin Labs Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Paladin Labs Recent Developments
11.3 Theramex (Teva)
11.3.1 Theramex (Teva) Company Information
11.3.2 Theramex (Teva) Overview
11.3.3 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Theramex (Teva) Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Long-acting and Short-acting Oral Contraceptives Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Pfizer Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Apotex
11.5.1 Apotex Company Information
11.5.2 Apotex Overview
11.5.3 Apotex Long-acting and Short-acting Oral Contraceptives Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Apotex Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Apotex Recent Developments
11.6 HRA Pharma
11.6.1 HRA Pharma Company Information
11.6.2 HRA Pharma Overview
11.6.3 HRA Pharma Long-acting and Short-acting Oral Contraceptives Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 HRA Pharma Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 HRA Pharma Recent Developments
11.7 HLL Life Care
11.7.1 HLL Life Care Company Information
11.7.2 HLL Life Care Overview
11.7.3 HLL Life Care Long-acting and Short-acting Oral Contraceptives Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 HLL Life Care Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 HLL Life Care Recent Developments
11.8 Mankind
11.8.1 Mankind Company Information
11.8.2 Mankind Overview
11.8.3 Mankind Long-acting and Short-acting Oral Contraceptives Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Mankind Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mankind Recent Developments
11.9 Piramal
11.9.1 Piramal Company Information
11.9.2 Piramal Overview
11.9.3 Piramal Long-acting and Short-acting Oral Contraceptives Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Piramal Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Piramal Recent Developments
11.10 Allergan
11.10.1 Allergan Company Information
11.10.2 Allergan Overview
11.10.3 Allergan Long-acting and Short-acting Oral Contraceptives Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Allergan Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Allergan Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Long-acting and Short-acting Oral Contraceptives Industry Chain Analysis
12.2 Long-acting and Short-acting Oral Contraceptives Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Long-acting and Short-acting Oral Contraceptives Production Mode & Process
12.4 Long-acting and Short-acting Oral Contraceptives Sales and Marketing
12.4.1 Long-acting and Short-acting Oral Contraceptives Sales Channels
12.4.2 Long-acting and Short-acting Oral Contraceptives Distributors
12.5 Long-acting and Short-acting Oral Contraceptives Customers
13 Market Dynamics
13.1 Long-acting and Short-acting Oral Contraceptives Industry Trends
13.2 Long-acting and Short-acting Oral Contraceptives Market Drivers
13.3 Long-acting and Short-acting Oral Contraceptives Market Challenges
13.4 Long-acting and Short-acting Oral Contraceptives Market Restraints
14 Key Findings in The Global Long-acting and Short-acting Oral Contraceptives Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Long-acting and Short-acting Oral Contraceptives Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Combined Contraceptive Pill
Table 3. Major Manufacturers of Low Dose Oral Contraceptive
Table 4. Global Long-acting and Short-acting Oral Contraceptives Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Long-acting and Short-acting Oral Contraceptives Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Long-acting and Short-acting Oral Contraceptives Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Long-acting and Short-acting Oral Contraceptives Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Region (2018-2024)
Table 9. Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Region (2024-2029)
Table 10. Global Long-acting and Short-acting Oral Contraceptives Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Long-acting and Short-acting Oral Contraceptives Sales by Region (2018-2024) & (K Units)
Table 12. Global Long-acting and Short-acting Oral Contraceptives Sales by Region (2024-2029) & (K Units)
Table 13. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Region (2018-2024)
Table 14. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Region (2024-2029)
Table 15. Global Long-acting and Short-acting Oral Contraceptives Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Long-acting and Short-acting Oral Contraceptives Sales Share by Manufacturers (2018-2024)
Table 17. Global Long-acting and Short-acting Oral Contraceptives Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Long-acting and Short-acting Oral Contraceptives Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Long-acting and Short-acting Oral Contraceptives, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Long-acting and Short-acting Oral Contraceptives Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Long-acting and Short-acting Oral Contraceptives Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Long-acting and Short-acting Oral Contraceptives by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting and Short-acting Oral Contraceptives as of 2022)
Table 23. Global Key Manufacturers of Long-acting and Short-acting Oral Contraceptives, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Long-acting and Short-acting Oral Contraceptives, Product Offered and Application
Table 25. Global Key Manufacturers of Long-acting and Short-acting Oral Contraceptives, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2024) & (K Units)
Table 28. Global Long-acting and Short-acting Oral Contraceptives Sales by Type (2024-2029) & (K Units)
Table 29. Global Long-acting and Short-acting Oral Contraceptives Sales Share by Type (2018-2024)
Table 30. Global Long-acting and Short-acting Oral Contraceptives Sales Share by Type (2024-2029)
Table 31. Global Long-acting and Short-acting Oral Contraceptives Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Long-acting and Short-acting Oral Contraceptives Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Long-acting and Short-acting Oral Contraceptives Revenue Share by Type (2018-2024)
Table 34. Global Long-acting and Short-acting Oral Contraceptives Revenue Share by Type (2024-2029)
Table 35. Long-acting and Short-acting Oral Contraceptives Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Long-acting and Short-acting Oral Contraceptives Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) & (K Units)
Table 38. Global Long-acting and Short-acting Oral Contraceptives Sales by Application (2024-2029) & (K Units)
Table 39. Global Long-acting and Short-acting Oral Contraceptives Sales Share by Application (2018-2024)
Table 40. Global Long-acting and Short-acting Oral Contraceptives Sales Share by Application (2024-2029)
Table 41. Global Long-acting and Short-acting Oral Contraceptives Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Long-acting and Short-acting Oral Contraceptives Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Long-acting and Short-acting Oral Contraceptives Revenue Share by Application (2018-2024)
Table 44. Global Long-acting and Short-acting Oral Contraceptives Revenue Share by Application (2024-2029)
Table 45. Long-acting and Short-acting Oral Contraceptives Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Long-acting and Short-acting Oral Contraceptives Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Long-acting and Short-acting Oral Contraceptives Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Long-acting and Short-acting Oral Contraceptives Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Long-acting and Short-acting Oral Contraceptives Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Long-acting and Short-acting Oral Contraceptives Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Long-acting and Short-acting Oral Contraceptives Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Long-acting and Short-acting Oral Contraceptives Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Long-acting and Short-acting Oral Contraceptives Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Long-acting and Short-acting Oral Contraceptives Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Long-acting and Short-acting Oral Contraceptives Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Long-acting and Short-acting Oral Contraceptives Sales by Country (2024-2029) & (K Units)
Table 60. Europe Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2024) & (K Units)
Table 61. Europe Long-acting and Short-acting Oral Contraceptives Sales by Type (2024-2029) & (K Units)
Table 62. Europe Long-acting and Short-acting Oral Contraceptives Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Long-acting and Short-acting Oral Contraceptives Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) & (K Units)
Table 65. Europe Long-acting and Short-acting Oral Contraceptives Sales by Application (2024-2029) & (K Units)
Table 66. Europe Long-acting and Short-acting Oral Contraceptives Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Long-acting and Short-acting Oral Contraceptives Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Long-acting and Short-acting Oral Contraceptives Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Long-acting and Short-acting Oral Contraceptives Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Long-acting and Short-acting Oral Contraceptives Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2024) & (K Units)
Table 72. Europe Long-acting and Short-acting Oral Contraceptives Sales by Country (2024-2029) & (K Units)
Table 73. China Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2024) & (K Units)
Table 74. China Long-acting and Short-acting Oral Contraceptives Sales by Type (2024-2029) & (K Units)
Table 75. China Long-acting and Short-acting Oral Contraceptives Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Long-acting and Short-acting Oral Contraceptives Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) & (K Units)
Table 78. China Long-acting and Short-acting Oral Contraceptives Sales by Application (2024-2029) & (K Units)
Table 79. China Long-acting and Short-acting Oral Contraceptives Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Long-acting and Short-acting Oral Contraceptives Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2024) & (K Units)
Table 82. Asia Long-acting and Short-acting Oral Contraceptives Sales by Type (2024-2029) & (K Units)
Table 83. Asia Long-acting and Short-acting Oral Contraceptives Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Long-acting and Short-acting Oral Contraceptives Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) & (K Units)
Table 86. Asia Long-acting and Short-acting Oral Contraceptives Sales by Application (2024-2029) & (K Units)
Table 87. Asia Long-acting and Short-acting Oral Contraceptives Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Long-acting and Short-acting Oral Contraceptives Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Long-acting and Short-acting Oral Contraceptives Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Long-acting and Short-acting Oral Contraceptives Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Long-acting and Short-acting Oral Contraceptives Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Long-acting and Short-acting Oral Contraceptives Sales by Region (2018-2024) & (K Units)
Table 93. Asia Long-acting and Short-acting Oral Contraceptives Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Sales by Country (2024-2029) & (K Units)
Table 107. Bayer Company Information
Table 108. Bayer Description and Major Businesses
Table 109. Bayer Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Bayer Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Bayer Recent Developments
Table 112. Paladin Labs Company Information
Table 113. Paladin Labs Description and Major Businesses
Table 114. Paladin Labs Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Paladin Labs Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Paladin Labs Recent Developments
Table 117. Theramex (Teva) Company Information
Table 118. Theramex (Teva) Description and Major Businesses
Table 119. Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Theramex (Teva) Recent Developments
Table 122. Pfizer Company Information
Table 123. Pfizer Description and Major Businesses
Table 124. Pfizer Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Pfizer Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Pfizer Recent Developments
Table 127. Apotex Company Information
Table 128. Apotex Description and Major Businesses
Table 129. Apotex Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Apotex Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Apotex Recent Developments
Table 132. HRA Pharma Company Information
Table 133. HRA Pharma Description and Major Businesses
Table 134. HRA Pharma Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. HRA Pharma Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. HRA Pharma Recent Developments
Table 137. HLL Life Care Company Information
Table 138. HLL Life Care Description and Major Businesses
Table 139. HLL Life Care Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. HLL Life Care Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. HLL Life Care Recent Developments
Table 142. Mankind Company Information
Table 143. Mankind Description and Major Businesses
Table 144. Mankind Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Mankind Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Mankind Recent Developments
Table 147. Piramal Company Information
Table 148. Piramal Description and Major Businesses
Table 149. Piramal Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Piramal Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Piramal Recent Developments
Table 152. Allergan Company Information
Table 153. Allergan Description and Major Businesses
Table 154. Allergan Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Allergan Long-acting and Short-acting Oral Contraceptives Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Allergan Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Long-acting and Short-acting Oral Contraceptives Distributors List
Table 160. Long-acting and Short-acting Oral Contraceptives Customers List
Table 161. Long-acting and Short-acting Oral Contraceptives Market Trends
Table 162. Long-acting and Short-acting Oral Contraceptives Market Drivers
Table 163. Long-acting and Short-acting Oral Contraceptives Market Challenges
Table 164. Long-acting and Short-acting Oral Contraceptives Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Long-acting and Short-acting Oral Contraceptives Product Picture
Figure 2. Global Long-acting and Short-acting Oral Contraceptives Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Long-acting and Short-acting Oral Contraceptives Market Share by Type in 2022 & 2029
Figure 4. Combined Contraceptive Pill Product Picture
Figure 5. Low Dose Oral Contraceptive Product Picture
Figure 6. Global Long-acting and Short-acting Oral Contraceptives Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Long-acting and Short-acting Oral Contraceptives Market Share by Application in 2022 & 2029
Figure 8. Hospital Pharmacies
Figure 9. Private Clinics
Figure 10. Retail Pharmacies
Figure 11. E-Commerce
Figure 12. Long-acting and Short-acting Oral Contraceptives Report Years Considered
Figure 13. Global Long-acting and Short-acting Oral Contraceptives Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Long-acting and Short-acting Oral Contraceptives Revenue 2018-2029 (US$ Million)
Figure 15. Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Region (2018-2029)
Figure 17. Global Long-acting and Short-acting Oral Contraceptives Sales 2018-2029 ((K Units)
Figure 18. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Long-acting and Short-acting Oral Contraceptives Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Long-acting and Short-acting Oral Contraceptives Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Long-acting and Short-acting Oral Contraceptives Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Long-acting and Short-acting Oral Contraceptives Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Long-acting and Short-acting Oral Contraceptives Sales YoY (2018-2029) & (K Units)
Figure 24. China Long-acting and Short-acting Oral Contraceptives Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Long-acting and Short-acting Oral Contraceptives Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Long-acting and Short-acting Oral Contraceptives Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Long-acting and Short-acting Oral Contraceptives Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Long-acting and Short-acting Oral Contraceptives in the World: Market Share by Long-acting and Short-acting Oral Contraceptives Revenue in 2022
Figure 31. Global Long-acting and Short-acting Oral Contraceptives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Type (2018-2029)
Figure 33. Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Type (2018-2029)
Figure 34. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Application (2018-2029)
Figure 35. Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Long-acting and Short-acting Oral Contraceptives Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Long-acting and Short-acting Oral Contraceptives Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Long-acting and Short-acting Oral Contraceptives Revenue Share by Country (2018-2029)
Figure 41. US & Canada Long-acting and Short-acting Oral Contraceptives Sales Share by Country (2018-2029)
Figure 42. U.S. Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Long-acting and Short-acting Oral Contraceptives Sales Market Share by Type (2018-2029)
Figure 45. Europe Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Type (2018-2029)
Figure 46. Europe Long-acting and Short-acting Oral Contraceptives Sales Market Share by Application (2018-2029)
Figure 47. Europe Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Application (2018-2029)
Figure 48. Europe Long-acting and Short-acting Oral Contraceptives Revenue Share by Country (2018-2029)
Figure 49. Europe Long-acting and Short-acting Oral Contraceptives Sales Share by Country (2018-2029)
Figure 50. Germany Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029) & (US$ Million)
Figure 51. France Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029) & (US$ Million)
Figure 55. China Long-acting and Short-acting Oral Contraceptives Sales Market Share by Type (2018-2029)
Figure 56. China Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Type (2018-2029)
Figure 57. China Long-acting and Short-acting Oral Contraceptives Sales Market Share by Application (2018-2029)
Figure 58. China Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Application (2018-2029)
Figure 59. Asia Long-acting and Short-acting Oral Contraceptives Sales Market Share by Type (2018-2029)
Figure 60. Asia Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Type (2018-2029)
Figure 61. Asia Long-acting and Short-acting Oral Contraceptives Sales Market Share by Application (2018-2029)
Figure 62. Asia Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Application (2018-2029)
Figure 63. Asia Long-acting and Short-acting Oral Contraceptives Revenue Share by Region (2018-2029)
Figure 64. Asia Long-acting and Short-acting Oral Contraceptives Sales Share by Region (2018-2029)
Figure 65. Japan Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029) & (US$ Million)
Figure 69. India Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Long-acting and Short-acting Oral Contraceptives Sales Share by Country (2018-2029)
Figure 76. Brazil Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Long-acting and Short-acting Oral Contraceptives Revenue (2018-2029) & (US$ Million)
Figure 81. Long-acting and Short-acting Oral Contraceptives Value Chain
Figure 82. Long-acting and Short-acting Oral Contraceptives Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed